The Gamble Behind a Takeover of Kenvue, Maker of Tylenol 04. November 2025 (14:57) Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.(New York Times)